Anjali Sharathkumar
Pediatric Hematology-Oncology · Iowa City, IANPI 1194945691
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,828 of the $61,435 with a category attached, or 92.5%. 11 manufacturers reported payments, led by Shire North American Group Inc at 29.0% of the total. Among pediatric hematology-oncology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $1097.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$18K
- Sanofi US Services Inc.$15K
- Genentech USA, Inc.$11K
- Spark Therapeutics, Inc.$6K
- Bayer$4K
- Boehringer Ingelheim$3K
- plus $5K from 5 others
Across 136 payments — averaging $13,640 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1.3M
- Pfizer$266K
- Boehringer Ingelheim$112K
- X4 Pharmaceuticals, Inc.$54K
- Diagnostica Stago, Inc$54K
- Bioverativ Therapeutics Inc.$33K
- plus $30K from 4 others
What the payments were for
- Consulting fees$56,82893%
- Travel & lodging$3,6106%
- Food & beverage$9722%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 20 | $17,804 |
| Sanofi US Services Inc. | 1 | $14,507 |
| Genentech USA, Inc. | 7 | $10,664 |
| Spark Therapeutics, Inc. | 7 | $6,133 |
| Bayer | 13 | $3,910 |
| Boehringer Ingelheim | 1 | $3,200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $2,600 |
| F. Hoffmann-la Roche AG | 1 | $2,420 |
| CSL Behring | 1 | $112 |
| Bio Products Laboratory USA, Inc. | 1 | $61 |
| Pfizer | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,435 in reported general payments places this provider in the 95th percentile of 21 pediatric hematology-oncology providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Iowa City
- Janice StaberIowa City$163K
- David DickensIowa City$4K
- Julie FischerIowa City$157
- Sara HortonIowa City$142
- Christopher BarnettIowa City$139
- Jenna GedminasIowa City$123
- Beeling ArmijoIowa City$33
- Krista GrindeIowa City$14
- William TerryIowa City$13
- David GordonIowa City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.